The Methodist Hospital Research Institute
Clinical trials sponsored by The Methodist Hospital Research Institute, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a simple nasal dilator quiet the ear symptoms of patulous eustachian tube? Results expected Nov 2026 (estimated)
- New combo therapy aims to boost prostate cancer fight before surgery Results expected Nov 2026 (estimated)
- New cocktail targets rare breast cancer that defies standard treatment Results expected Dec 2026 (estimated)
- Could a peptide supercharge COVID-19 vaccines for seniors? Results expected Dec 2026 (estimated)
- Can a steroid blast calm kidney stent pain? Results expected Dec 2026 (estimated)
-
Can an extra surgical step make bunion correction last longer?
Disease control OngoingThis trial tests whether adding a lateral soft tissue release to standard chevron bunion surgery improves the correction of the big toe's angle and reduces the chance of the bunion returning. About 200 adults with mild to moderate bunions will be randomly assigned to receive eith…
Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can digital tools and training help more kidney patients get transplants?
Disease control OngoingThis trial tests a comprehensive approach to improve kidney care and increase transplant rates. It combines provider training, digital dashboards, and a mobile health app to educate patients and help them find living donors. The study includes 5,000 adults with advanced chronic k…
Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New drug cocktail targets Hard-to-Treat breast cancer
Disease control OngoingThis phase 2 trial tests whether adding the immunotherapy drug durvalumab to two standard targeted drugs (trastuzumab and pertuzumab) can shrink tumors more effectively in people with HER2-enriched breast cancer. The study involves 51 participants and measures how many have no or…
Phase 2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Could a simple cuff boost wrist fracture recovery?
Disease control OngoingThis study tests whether adding a blood flow restriction (BFR) cuff to standard physical therapy helps people recover better after wrist fracture surgery. The cuff is placed on the arm during low-intensity exercises to mimic the effects of high-intensity training. Researchers wil…
Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug combo targets Hard-to-Treat breast cancer
Disease control OngoingThis early-stage trial tests the safety of combining two drugs, olaparib and vorinostat, in people with advanced breast cancer that has returned or spread. About 28 participants will receive the combination to find the best dose and check for side effects. The goal is to see if t…
Phase 1 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can immunotherapy before surgery help fight melanoma?
Disease control OngoingThis early-phase trial is testing whether the immunotherapy drug atezolizumab (Tecentriq) is safe to use before surgery in people with high-risk melanoma that hasn't spread. The study includes 20 participants and focuses on whether the treatment causes side effects that delay the…
Phase 1 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a cancer drug protect new kidneys from scarring?
Disease control By invitation onlyThis phase 2 trial tests whether adding belumosudil (Rezurock) to standard care can prevent scarring in new kidney transplants. About 40 adults receiving their first or second kidney will be randomly assigned to get the drug or a placebo for a year. The study tracks serious side …
Phase 2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Bladder cancer patients who Can't take chemo may get new option
Disease control OngoingThis phase II trial tests a combination of an immunotherapy drug called sasanlimab and focused radiation given before bladder removal surgery in 33 patients with muscle-invasive bladder cancer who cannot take standard chemotherapy. The goal is to see if this approach is safe, fea…
Phase 2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Bone injection vs. IV: which antibiotic route wins for shoulder surgery?
Disease control OngoingThis study tests whether injecting the antibiotic vancomycin directly into the shoulder bone works as well as giving it through a vein during shoulder replacement surgery. About 33 adults having shoulder replacement will be split into two groups to compare antibiotic levels in bo…
Phase 4 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could a simple tourniquet change cut Post-Surgery pain and opioid use?
Symptom relief OngoingThis study tests whether using a lower-pressure tourniquet during orthopedic surgeries can reduce pain and the need for opioid painkillers afterward. Standard tourniquets use high pressure, which can cause muscle weakness and pain. The experimental device sets pressure based on t…
Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Surgeons test wearing a VR headset instead of staring at a screen
Knowledge-focused By invitation onlyThis study tests whether surgeons can wear an Apple Vision Pro headset as a virtual monitor while performing their usual procedures, instead of looking at a traditional operating room screen. The goal is to compare image quality, comfort, and workload against a standard monitor. …
Sponsor: The Methodist Hospital Research Institute • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
A new tool aims to predict and prevent living kidney donor Drop-Out
Knowledge-focused OngoingThis study focuses on people from racial and ethnic minority groups who volunteer to donate a kidney but often stop the evaluation process before donation. Researchers are building a risk index to identify who is likely to drop out, then testing a six-month support program delive…
Sponsor: The Methodist Hospital Research Institute • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC